Deciphering the Mystery: Extracorporeal Photopheresis in Graft-versus-Host Disease
- PMID: 26386319
- PMCID: PMC6786786
- DOI: 10.1016/j.bbmt.2015.09.011
Deciphering the Mystery: Extracorporeal Photopheresis in Graft-versus-Host Disease
Conflict of interest statement
Comment on
-
Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation.Biol Blood Marrow Transplant. 2015 Nov;21(11):1921-5. doi: 10.1016/j.bbmt.2015.05.024. Epub 2015 May 30. Biol Blood Marrow Transplant. 2015. PMID: 26033279
Similar articles
-
Bring on the Biosimilars!Biol Blood Marrow Transplant. 2015 Nov;21(11):1859-60. doi: 10.1016/j.bbmt.2015.09.010. Epub 2015 Sep 18. Biol Blood Marrow Transplant. 2015. PMID: 26386317 No abstract available.
-
Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation.Biol Blood Marrow Transplant. 2015 Nov;21(11):1921-5. doi: 10.1016/j.bbmt.2015.05.024. Epub 2015 May 30. Biol Blood Marrow Transplant. 2015. PMID: 26033279
-
Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients.Cytotherapy. 2015 Oct;17(10):1485-93. doi: 10.1016/j.jcyt.2015.05.010. Epub 2015 Jul 15. Cytotherapy. 2015. PMID: 26188967
-
Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting).Leuk Lymphoma. 2016;57(6):1256-68. doi: 10.3109/10428194.2015.1131278. Epub 2016 Jan 6. Leuk Lymphoma. 2016. PMID: 26735310 Review.
-
The role of pegfilgrastim in mobilization of hematopoietic stem cells.Transfus Apher Sci. 2008 Jun;38(3):237-44. doi: 10.1016/j.transci.2008.04.007. Epub 2008 May 19. Transfus Apher Sci. 2008. PMID: 18490197 Review.
Cited by
-
Monocytes show immunoregulatory capacity on CD4+ T cells in a human in-vitro model of extracorporeal photopheresis.Clin Exp Immunol. 2019 Mar;195(3):369-380. doi: 10.1111/cei.13232. Epub 2018 Nov 22. Clin Exp Immunol. 2019. PMID: 30411330 Free PMC article.
-
Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers.Front Immunol. 2023 Feb 17;14:1086006. doi: 10.3389/fimmu.2023.1086006. eCollection 2023. Front Immunol. 2023. PMID: 36875063 Free PMC article. Review.
-
Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects.Front Immunol. 2018 Oct 8;9:2207. doi: 10.3389/fimmu.2018.02207. eCollection 2018. Front Immunol. 2018. PMID: 30349527 Free PMC article.
References
-
- Ratcliffe N, Dunbar NM, Adamski J, et al. National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: scientific opportunities in extracorporeal photopheresis. Transfus Med Rev 2015; 29:62–70. - PubMed
-
- Berger M, Pessolano R, Albiani R, et al. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report. J Pediatr Hematol Oncol 2007;29:678–687. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical